InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Haskel William M., Executive. Officer active across 1 company, notably Paratek Pharmaceuticals, Inc.. Aggregated, 12 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €61k. History available since 27 May 2021. The latest transaction was filed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Haskel William M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
357,774 sharesCommon StockSEC:0000899243-23-019361:0
73,750 shares0Common StockSEC:0000904454-23-000474:0
15,000 shares0Common StockSEC:0000904454-22-000651:0
14,410 shares@ US$1.9833.7% of flowCommon StockSEC:0000904454-22-000625:0
4,382 shares@ US$3.4719.0% of flowCommon StockSEC:0000904454-22-000530:0
9,250 shares0Common StockSEC:0000904454-22-000508:0
47,727 shares0Common StockSEC:0000904454-22-000427:0
67,500 shares0Common StockSEC:0000904454-22-000266:0
4,876 shares@ US$4.4231.0% of flowCommon StockSEC:0000904454-21-000842:0
23,125 shares0Common StockSEC:0000904454-21-000628:0
28,636 shares0Common StockSEC:0000904454-21-000518:0
11,000 sharesCommon StockSEC:0000904454-16-000928:0
12 of 12 declarations
About Haskel William M.
Haskel William M. is a Dirigeant associated with Paratek Pharmaceuticals, Inc., where he is CLO, General Counsel & Sec. The record shows 12 filings in total, and among the sampled recent filings they run from 2016-02-08 to 2023-09-21, with 0 in purchases and 61,423 in sales in EUR. The most common transaction nature is Attribution.
